Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Once a tirzepatide prescription is deemed appropriate, our team submits the necessary requests to your insurance provider
Market Players, Key Developments, and Competitive Intelligence To learn more about this report, Key Developments On June 30, 2025, Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on peptide-based therapeutics, announced the nomination of PN-477, a triple agonist peptide targeting GLP-1, GIP, and GCG receptors, for obesity treatment
Use of GLP-1 receptor agonists in pregnancy and reproductive safety: results from the European Teratology Information Services study
Vitamin D, a modulator of musculoskeletal health in chronic kidney disease
Do the claims match the science
US$ 28.88
US$ 24.89
US$ 23.11
US$ 20.86
